Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1365711 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
5′-Phenyl-3′H-spiro[indoline-3,2′-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (Aggrecanase-2) have been prepared via commercially available starting materials. Selected compounds 23, 33–35 show sub-micromolar ADAMTS-5 potency and strong SAR trends with selectivity over the related metalloproteases ADAMTS-4 (Aggrecanase-1), MMP12, and MMP13. This series of compounds represents progress toward a selective ADAMTS-5 inhibitor as a disease modifying osteoarthritis drug.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Matthew G. Bursavich, Adam M. Gilbert, Sabrina Lombardi, Katy E. Georgiadis, Erica Reifenberg, Carl R. Flannery, Elisabeth A. Morris,